Education
Bachelor’s Degree – Vanderbilt University
Medical Degree – Boston University
Internship – Boston City Hospital
Residency – Boston City Hospital
Fellowship – Mount Sinai Hospital
Board Certifications – Gastroenterology, Internal Medicine
Honors & Awards
- Castle Connolly Top Doctors, 2018-present
- AOA honors in medical school at Boston city Hospital
- Graduated magma cum Laude from Vanderbilt
Specialties & Main Areas of Interest
- All GI disorders
Hospital Affiliations
- Good Samaritan
- Montefiore Nyack Hospital
Other Appointments
- Clinical Instructor, Mount Sinai Medical Center
Research
- Goldenberg, A.M, Present, D.H., Bauer, J., Gordon, R. Islet Cell Tumor Presenting as Massive Upper Gastrointestinal Bleeding in Pregnancy. American Journal of Gastroenterology: 1988;83: 873-75
- Goldenberg, A.M, Wexler, L.F. Quinine Overdose: Review of Toxicity and Treatment Clinical Cardiology 1988; II :716-18
- Itzkowitz, S.H., Lee H, Hanauer S, Goldenberg, A.M, Kim, Y.S. New Biochemical Markers Associates with Dysplasia in Ulcerative Colitis Gastroenterology 1987;92 (5): 1449
- Itzkowitz, S.H, Lee H, Hanauer, S, Goldenberg, A.M, Kim, Y.S. Cancer-Associated Alterations in Blood Group Antigen Expression Occurring in Ulcerative Colitis.
- 2000 – Rabeprazole FAST trial (Janssen)
- 2000 – A Twelve Week Randomized Double-Blind, Placebo Controlled Study of the Efficacy and Tolerability of Alosetron Hydrochloride 1 mg. Twice daily for the control of bowel urgency in females with non-constipated JBS in an Independent Practitioner Association Model. Protocol #S3B40051
- 2000 – START: Standard Therapeutic Assessment of Rebetron Trial. Indiana University, Indiana Gastroenterology 1988;94 (5); 1449
- 2000 – A Comparative Efficacy Study of Esomeprazole Magnesium (40 mg qd) and Lansoprazole (30mgs qd) in Patients with Erosive Esophagitis. Protocol #267
- May 2001 – Completed: Roche Laboratories, Inc. A Prospective Randomized Multicenter, Open Label, Comparative Safety Study of Pegasys vs. Pegasys Plus Ribavirin in Treatment of Patients with Hep C “Wings Trial”.
- March 2001 – Completed: Proctor & Gamble. Asacol 4.8gm/day vs 2.4 gm/day in mild to moderate ulcerative colitis patients experiencing an active flare.
- April 2003 – Abbott Laboratories: A Multi-Center, Randomized, Double-Blind, PlaceboControlled Study of Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects with Crohn’s Disease.
- September 2003 – GlaxoSmithK.line-A 12-week, Randomized, Double-Blind, Placebo Controlled Study of PRN BID and Fixed Dosing Regimens of Alosetron in Female Subjects with Severe Diarrhea-Predominant Irritable Bowel Syndrome Who Have Failed Conventional Therapy.
Fun Facts
- Dr. Goldenberg enjoys playing golf, fishing, exercising, and traveling. He also
was a jazz lead trumpet player and has recorded three albums.
Conditions & Diseases Treated
- Abdominal Pain
- Achalasia
- Acid Reflux
- Anorectal Disease
- Bacteria and Foodborne Illness
- Barrett's Esophagus
- Bile Duct Blockages and Stones
- Celiac Disease
- Chronic Diarrhea
- Clostridioides Difficile
- Colon Cancer
- Colon Disease
- Colon Polyps
- Colorectal Cancer
- Constipation
- Crohn’s and Ulcerative Colitis
- Diarrhea
- Difficulty Swallowing (Dysphagia)
- Diverticulosis/Diverticulitis
- Esophageal Cancer
- Esophagitis and Stricture
- Fatty Liver
- Fecal Incontinence
- Gallbladder Disease
- Gallstones
- Gas
- Gastric Cancer
- Gastritis
- Gastrointestinal Malignancies
- Gastroparesis
- Genetic Colon Cancer Syndromes
- GERD
- H. Pylori and Peptic Ulcer
- Heartburn
- Helicobacter Pylori/Peptic Ulcer
- Hemochromatosis
- Hemorrhoids
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Hepatocellular Carcinoma
- Hernias (Abdominal, Groin, and Hiatal)
- High-Risk Colon Cancer Screening
- Inflammatory Bowel Disease, Including Crohn’s Disease and Ulcerative Colitis
- Iron Deficiency Anemia
- Irritable Bowel Syndrome
- Jaundice
- Lactose Intolerance
- Laryngopharyngeal Reflux
- Liver Cirrhosis
- Liver Disease
- Nausea and Vomiting
- Nonalcoholic Steatohepatitis (NASH)
- Obesity
- Pancreatic Cancer
- Pancreatic Cysts
- Pancreatitis
- Peptic Ulcer Disease (PUD)
- Primary Biliary Cirrhosis
- Proctitis
- Rectal Bleeding
- Rectal Cancer
- Reflux Esophagitis/Stricture
- Silent Reflux
- Stomach Ulcers
- Swallowing Difficulty
- Ulcerative Colitis
Procedures Performed
- Anorectal Manometry
- Bacterial Overgrowth Test
- Barrett’s Treatment
- Bravo pH Study
- Breath Testing, including Lactose, Lactulose, Fructose Testing
- Capsule Endoscopy
- Cholangioscopy
- Colonoscopy
- Complex Polypectomy
- Diagnostic & Therapeutic Colonoscopy
- Diagnostic & Therapeutic Endoscopy
- Endoscopic Mucosal Resection
- Endoscopic Pseudocyst Drainage
- Endoscopic Retrograde Cholangiopancreatography (ERCP)
- Enteral Stents
- ERCP
- Esophageal Dilation/Testing
- Esophageal High Resolution Manometry and 24 Hr pH Impedance Testing
- Fecal Transplant
- Flexible Sigmoidoscopy
- Flexible Sigmoidoscopy and IRC
- Hemorrhoid Banding
- Hemorrhoid Infrared Coagulation Therapy
- Hemorrhoid Treatments (IRC and Banding)
- Lactose Intolerance Breath Test
- Lactose Tolerance Test
- Luminal Stent
- Percutaneous Endoscopic Gastrostomy (PEG)
- Percutaneous Endoscopic Jejunostomy (PEJ)
- Polypectomy
- Push Enteroscopy
- Radiofrequency Ablation of Barrett's
- Remicade Infusion
- SpyGlass Cholangioscopy
- Upper Endoscopy
- Upper GI Endoscopy (EGD)
- Urea Breath Test (UBT)
- Variceal Banding
